MCIR1: A patient‐derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance.

Saved in:
Bibliographic Details
Title: MCIR1: A patient‐derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance.
Authors: Wu, Xiaosheng1 (AUTHOR), Nowakowski, Kevin E.1 (AUTHOR), Abeykoon, Jithma P.1 (AUTHOR), Manske, Michelle1 (AUTHOR), Stenson, Mary J.1 (AUTHOR), Timm, Michael M.2 (AUTHOR), Hanson, Curtis A.2 (AUTHOR), Van Dyke, Daniel L.2 (AUTHOR), Dasari, Surendra3 (AUTHOR), Witzig, Thomas E.1 (AUTHOR) witzig.thomas@mayo.edu
Source: European Journal of Haematology. Oct2021, Vol. 107 Issue 4, p458-465. 8p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09024441
DOI:10.1111/ejh.13682